DK438288A - Hybrid picornavirus samt fremgangsmaade til fremstilling deraf og vaccine paa basis af en saadan virus - Google Patents

Hybrid picornavirus samt fremgangsmaade til fremstilling deraf og vaccine paa basis af en saadan virus

Info

Publication number
DK438288A
DK438288A DK438288A DK438288A DK438288A DK 438288 A DK438288 A DK 438288A DK 438288 A DK438288 A DK 438288A DK 438288 A DK438288 A DK 438288A DK 438288 A DK438288 A DK 438288A
Authority
DK
Denmark
Prior art keywords
virus
producing
vaccine based
picornavirus
hybrid
Prior art date
Application number
DK438288A
Other languages
Danish (da)
English (en)
Other versions
DK438288D0 (da
Inventor
Marc Girard
Cyslaw Wychowski
Annette Martin
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of DK438288D0 publication Critical patent/DK438288D0/da
Publication of DK438288A publication Critical patent/DK438288A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK438288A 1987-08-07 1988-08-05 Hybrid picornavirus samt fremgangsmaade til fremstilling deraf og vaccine paa basis af en saadan virus DK438288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711337A FR2619012B1 (fr) 1987-08-07 1987-08-07 Vaccins dont l'epitope caracteristique est incorpore dans une proteine de picornavirus, notamment de poliovirus

Publications (2)

Publication Number Publication Date
DK438288D0 DK438288D0 (da) 1988-08-05
DK438288A true DK438288A (da) 1989-04-10

Family

ID=9354047

Family Applications (1)

Application Number Title Priority Date Filing Date
DK438288A DK438288A (da) 1987-08-07 1988-08-05 Hybrid picornavirus samt fremgangsmaade til fremstilling deraf og vaccine paa basis af en saadan virus

Country Status (11)

Country Link
EP (1) EP0302801B1 (de)
JP (1) JPH01157380A (de)
AR (1) AR242057A1 (de)
AT (1) ATE129288T1 (de)
DE (1) DE3854591D1 (de)
DK (1) DK438288A (de)
FR (1) FR2619012B1 (de)
OA (1) OA08749A (de)
PT (1) PT88219B (de)
WO (1) WO1989001516A1 (de)
ZA (1) ZA885774B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614404A (en) * 1988-06-10 1997-03-25 Theriod Biologics, Incorporated Self-assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) * 1988-06-10 1998-05-05 Therion Biologics Corporation Self-assembled, defective, non-self-propagating lentivirus particles
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2055613A1 (en) * 1989-05-31 1990-12-01 Jeffrey W. Almond Poliovirus chimaeras
GB8912496D0 (en) * 1989-05-31 1989-07-19 Medical Res Council Vaccines
JP3034025B2 (ja) * 1989-06-01 2000-04-17 アプライド・バイオテクノロジー・インコーポレーテツド 自己アセンブルド欠損非自己増殖性ウイルス粒子
US5817491A (en) * 1990-09-21 1998-10-06 The Regents Of The University Of California VSV G pseusdotyped retroviral vectors
US5512421A (en) * 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
DE69131908T3 (de) * 1991-02-19 2008-04-03 Oxford Biomedica (Uk) Ltd. Viruspartikel mit veraendertem wirtspektrum
GB9125896D0 (en) * 1991-12-05 1992-02-05 Almond Jeffrey W Bicistronic viruses
EP0702724A1 (de) * 1993-06-03 1996-03-27 Institut Pasteur Mengovirus als vektor für die expression von freundpolypeptiden
US6071742A (en) 1997-03-05 2000-06-06 Board Of Regents Of The University Of Nebraska Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
WO2000014263A2 (en) * 1998-09-03 2000-03-16 Board Of Regents, The University Of Texas System Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
JP4753943B2 (ja) 2004-07-13 2011-08-24 ジェン−プローブ・インコーポレーテッド Ａ型肝炎ウイルス核酸の検出のための組成物及び方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins

Also Published As

Publication number Publication date
ZA885774B (en) 1989-04-26
PT88219A (pt) 1989-06-30
EP0302801A1 (de) 1989-02-08
WO1989001516A1 (fr) 1989-02-23
ATE129288T1 (de) 1995-11-15
FR2619012A1 (fr) 1989-02-10
DE3854591D1 (de) 1995-11-23
AR242057A1 (es) 1993-02-26
FR2619012B1 (fr) 1989-12-22
JPH01157380A (ja) 1989-06-20
EP0302801B1 (de) 1995-10-18
PT88219B (pt) 1995-09-12
OA08749A (fr) 1989-03-31
DK438288D0 (da) 1988-08-05

Similar Documents

Publication Publication Date Title
DK438288D0 (da) Hybrid picornavirus samt fremgangsmaade til fremstilling deraf og vaccine paa basis af en saadan virus
DK581789D0 (da) Fremgangsmaade til genvinding af ethan
DK390D0 (da) Fremgangsmaade til fremstilling af hydroxylapatit
DK149589D0 (da) Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme
DK412284A (da) Vacciner baseret paa membran-bundne proteiner og fremgangsmaade til fremstilling deraf
DK142989D0 (da) Fremgangsmaade til fremstilling af 2ae'-o-demethyltylosin
DE68903399D1 (de) Verfahren zur gasphasenfluorierung.
DK14788D0 (da) Fremgangsmaade til fremstilling af en herbicid emulsion
FI872769L (fi) Menetelmä alfa-mono-olefiinien polymeroimiseksi
DK234590A (da) Fremgangsmaade til behandling af retrovirusinfektioner
FI894544A7 (fi) Menetelmä styreeniin pohjautuvien polymeerien valmistamiseksi
DE3769608D1 (de) Verfahren zur zubereitung von hitzebestaendigen kolophonium-estern.
DK21489A (da) Plade til en vaeg, system med en saadan plade og fremgangsmaade til brug af pladen
DK503488D0 (da) Fremgangsmaade til fremstilling af polymere
FI892683A7 (fi) Menetelmä ei-hyperglykosyloitujen hepatiitti-B-virusproteiinien tuottamiseksi
DE3777024D1 (de) Verfahren und vorrichtung, um einen magnetkopf freizugeben.
DK14589D0 (da) Fremgangsmaade til fremstilling af 1-alkyl-5-nitroimidazoler
DK388787D0 (da) Fremgangsmaade til fremstilling af interferon
DK39789A (da) Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre
DK3588D0 (da) Fremgangsmaade til fremstilling af et plastroer
FI882041L (fi) Menetelmä elävän herpesvirusrokotteen lyofilisoimiseksi
DK471588A (da) Fremgangsmaade til fremstilling af polymerer
DK358288A (da) Fremgangsmaade til fremstilling af 2-arylthiobenzoesyrer
FI885796L (fi) Menetelmä polymeroidun kolofoniumhartsin stabiloimiseksi
DK277688D0 (da) Fremgangsmaade til fremstilling af et hmg-coa-lignende protein

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment